Betaserc 8 mg 100 tablets
Composition
Each tablet contains betahistine dihydrochloride 8 mg.
Excipients
microcrystalline cellulose, mannitol, citric acid monohydrate, colloidal silicon dioxide, talc.
Product Description
Betaserc is a synthetic analogue of histamine.
It acts mainly on histamine H1‑receptors, causes precapillary dilation, and improves microcirculation in the labyrinth.
It regulates endolymphatic pressure in the labyrinth and cochlea, leading to clinical improvement in vertigo of various origins.
It reduces the frequency and intensity of dizziness, decreases tinnitus, and helps improve hearing.
It may increase the tone of smooth muscles in the bronchi and gastrointestinal tract, and can enhance gastric juice secretion.
Indications for Use
Ménière’s syndrome,
manifested by dizziness (with nausea and vomiting),
hearing loss (hypoacusis), and tinnitus.
Symptomatic treatment of vestibular vertigo.
Method of Administration and Dosage
The optimal dosing regimen is determined by the physician.
Single dose: 8–16 mg, taken three times daily.
Treatment is long‑term.
To reduce dyspeptic symptoms, it is recommended to take during or after meals.
Contraindications
Hypersensitivity to betahistine.
Pheochromocytoma.
Peptic ulcer of the stomach or duodenum in the acute phase.
Bronchial asthma.
First trimester of pregnancy.
Use with caution in the second and third trimesters, during breastfeeding, and in children.
Precautions
Use cautiously in patients with a history of gastric or duodenal ulcer.
Clinical effect is achieved after several months of treatment.
Adverse Reactions / Side Effects
Gastrointestinal: mild nausea, feeling of heaviness in the epigastrium.
Allergic reactions: skin rash, itching, urticaria.
Pregnancy and Lactation
Contraindicated in the first trimester of pregnancy.
In the second and third trimesters, and during breastfeeding, use only as prescribed by a physician.
Storage Conditions
Store at a temperature not exceeding 30°C.
Packaging
Cardboard box containing 100 tablets and a paper leaflet.